Ajooni Biotech Limited — Important, 31-05-2025: Updates

Ajooni Biotech has announced a board meeting to approve the financial results for the quarter and half-year. Q4 total income rose 54% YoY to ₹30.61 Cr, while PAT increased 68% to ₹1.54 Cr, driven by better operational efficiency. For FY25, total income climbed 42% to ₹116.76 Cr, with PAT up 56% to ₹3.37 Cr. Expansion into B2C, 300+ new dealers, repeat export orders from Bangladesh, entry into Gujarat’s cattle feed market, and an MOU to enhance feed supply and R&D in North India indicate strong growth prospects ahead.